CERIBELLI, Angela
 Distribuzione geografica
Continente #
EU - Europa 4.721
NA - Nord America 2.621
AS - Asia 1.255
SA - Sud America 187
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 8.812
Nazione #
IT - Italia 3.547
US - Stati Uniti d'America 2.565
CN - Cina 453
SG - Singapore 438
DE - Germania 229
UA - Ucraina 227
BR - Brasile 156
FR - Francia 153
GB - Regno Unito 112
IE - Irlanda 104
HK - Hong Kong 102
VN - Vietnam 94
FI - Finlandia 75
RU - Federazione Russa 65
TR - Turchia 45
IN - India 43
NL - Olanda 41
ES - Italia 33
CA - Canada 29
EE - Estonia 23
BD - Bangladesh 20
RO - Romania 20
SE - Svezia 16
MX - Messico 15
PL - Polonia 14
AR - Argentina 13
BE - Belgio 12
JP - Giappone 10
CH - Svizzera 9
AT - Austria 8
IQ - Iraq 7
PK - Pakistan 7
ZA - Sudafrica 6
EC - Ecuador 5
ID - Indonesia 5
PA - Panama 5
LT - Lituania 4
LU - Lussemburgo 4
NG - Nigeria 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CO - Colombia 3
DK - Danimarca 3
DZ - Algeria 3
EU - Europa 3
IR - Iran 3
JO - Giordania 3
KZ - Kazakistan 3
LI - Liechtenstein 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
VE - Venezuela 3
CY - Cipro 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
PE - Perù 2
SA - Arabia Saudita 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MS - Montserrat 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PY - Paraguay 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 8.812
Città #
Milan 259
Singapore 244
Fairfield 240
Ashburn 204
Rome 197
Woodbridge 194
Jacksonville 171
Beijing 143
Houston 126
San Jose 119
Cambridge 107
Florence 107
Hong Kong 101
The Dalles 93
Seattle 91
Ann Arbor 89
Wilmington 87
New York 77
Chandler 74
Princeton 74
Los Angeles 63
Nanjing 59
Trieste 57
Turin 57
Bologna 48
Helsinki 44
Dublin 42
Verona 37
Ho Chi Minh City 35
Istanbul 35
Udine 35
Genoa 33
Dallas 32
Padova 32
Lauterbourg 31
Brescia 30
Munich 26
Des Moines 25
Moscow 24
Pisa 24
Genova 23
Tallinn 23
Modena 22
Syracuse 21
Lancaster 20
Menlo Park 20
Reggio Nell'emilia 20
Nanchang 19
San Diego 19
Naples 18
Buffalo 16
London 16
Mumbai 16
Torino 16
Trento 16
Bari 15
Hanoi 15
Shenyang 15
Bergamo 14
Catania 14
Chicago 13
Desio 13
Hebei 13
Sassari 13
Tianjin 13
Venice 13
Brooklyn 12
Brussels 12
Dearborn 12
Manchester 12
San Francisco 12
Changsha 11
Council Bluffs 11
Jiaxing 11
Palermo 11
Redwood City 11
Shanghai 11
Frankfurt am Main 10
Orem 10
Pozzuolo Del Friuli 10
Redondo Beach 10
Tokyo 10
Cosenza 9
Montreal 9
Perugia 9
São Paulo 9
Turriaco 9
Cagliari 8
Fiumicino 8
Francenigo 8
Napoli 8
Pescara 8
Santa Clara 8
Stockholm 8
Hangzhou 7
Kunming 7
Lecco 7
Manresa 7
Messina 7
Phoenix 7
Totale 4.321
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.376
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.817
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 219
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 216
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 215
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 194
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 182
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 179
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. 178
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 174
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 162
Autoimmune polyendocrine Syndromes 154
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 154
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 148
IL COMPLEMENTO NELLA GRAVIDANZA DI DONNE AFFETTE DA SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA 130
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 129
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 123
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 120
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 119
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 117
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 116
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 115
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 115
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 113
Complement cascade in systemic lupus erythematosus: Analyses of the three activation pathways 107
Comparison of early and late onset systemic lupus erythematosus 107
FIRST REPORT OF ANTI-MDA5 ANTIBODIES IN A COHORT OF ITALIAN PATIENTS WITH DERMATOMYOSITIS: CLINICAL AND SEROLOGIC CORRELATIONS 94
The clinical phenotype of Systemic Sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort 91
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 90
Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses 84
Studio ecocardiografico in pazienti affetti da artrite reumatoide. 83
DETECTION OF ANTI-ARGONAUTE2 (AGO2/SU) AND -RO ANTIBODIES BY IMMUNOPRECIPITATION, IN PRIMARY ANTI-PHOSPHOLIPID SYNDROME (PAPS) PATIENTS: ARE THEY PREDICTIVE FOR EVOLUTION IN SYSTEMIC LUPUS ERYTHEMATOSUS? 79
Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity 77
Left ventricular Systolic and diastolic function in rheumatoid arthritis 77
Left ventricular sistolic and diastolic function in rheumatoid arthritis. 75
LEFT VENTRICULAR FUNCTION IN RHEUMATOID ARTHRITIS DURING ANTI-TNF ALPHA TREATMENT: PROSPECTIVE STUDY 74
STUDIO ECOCARDIOGRAFICO IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE 72
Hepatitis C virus infection and primary Sjögren's Syndrome: A clinical and serologic description of 9 patients 71
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 69
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 68
Totale 8.883
Categoria #
all - tutte 26.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.555


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 0 0 0 0 0 77 109 46
2021/20221.052 53 137 66 43 99 90 124 70 83 91 86 110
2022/2023729 78 20 32 27 49 113 27 68 149 38 67 61
2023/2024621 29 32 51 36 34 97 56 30 98 35 48 75
2024/20251.146 56 48 39 142 131 113 85 79 93 77 172 111
2025/20261.676 160 227 112 256 191 149 282 88 115 96 0 0
Totale 8.883